Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

The kidney as a reservoir for HIV-1 after renal transplantation.

Canaud G, Dejucq-Rainsford N, Avettand-Fenoël V, Viard JP, Anglicheau D, Bienaimé F, Muorah M, Galmiche L, Gribouval O, Noël LH, Satie AP, Martinez F, Sberro-Soussan R, Scemla A, Gubler MC, Friedlander G, Antignac C, Timsit MO, Onetti Muda A, Terzi F, Rouzioux C, Legendre C.

J Am Soc Nephrol. 2014 Feb;25(2):407-19. doi: 10.1681/ASN.2013050564. Epub 2013 Dec 5.

2.

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.

Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL.

Transplantation. 2003 Jul 27;76(2):370-5.

PMID:
12883195
3.

The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study.

Mahmoud IM, Elhabashi AF, Elsawy E, El-Husseini AA, Sheha GE, Sobh MA.

Am J Kidney Dis. 2004 Jan;43(1):131-9.

PMID:
14712436
4.

[Renal transplantation in HIV-infected patients in Spain].

Mazuecos A, Pascual J, Gómez E, Sola E, Cofán F, López F, Puig-Hooper CE, Baltar JM, González-Molina M, Oppenheimer F, Marcén R, Rivero M.

Nefrologia. 2006;26(1):113-20. Spanish.

5.

Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology.

Drachenberg CB, Beskow CO, Cangro CB, Bourquin PM, Simsir A, Fink J, Weir MR, Klassen DK, Bartlett ST, Papadimitriou JC.

Hum Pathol. 1999 Aug;30(8):970-7.

PMID:
10452511
6.

The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.

Denewar AA, Monem El-Hendy YA, Wafa EW, Ghorab AA, Sheashaa HA, Rashad RH, Nagib AM, Neamatallah AH, Abbas MH, Shokeir AA.

Exp Clin Transplant. 2015 Oct;13(5):402-7.

7.

Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.

Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH.

N Engl J Med. 2000 May 4;342(18):1309-15.

8.

Renal epithelium is a previously unrecognized site of HIV-1 infection.

Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE.

J Am Soc Nephrol. 2000 Nov;11(11):2079-87.

9.

Adverse impact of pretransplant polyoma virus infection on renal allograft function.

Hayat A, Mukhopadhyay R, Radhika S, Sachdeva MS, Nada R, Joshi K, Sakhuja V, Jha V.

Nephrology (Carlton). 2008 Apr;13(2):157-63. doi: 10.1111/j.1440-1797.2007.00861.x.

PMID:
18275505
10.

HIV-associated nephropathy: experimental models.

Avila-Casado C, Fortoul TI, Chugh SS.

Contrib Nephrol. 2011;169:270-85. doi: 10.1159/000320212. Epub 2011 Jan 20.

PMID:
21252526
11.

HIV Infection in the Native and Allograft Kidney: Implications for Management, Diagnosis, and Transplantation.

Avettand-Fenoël V, Rouzioux C, Legendre C, Canaud G.

Transplantation. 2017 Sep;101(9):2003-2008. doi: 10.1097/TP.0000000000001674. Review.

PMID:
28196049
12.

Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.

Sabry A.

Exp Clin Transplant. 2010 Jun;8(2):91-7. Erratum in: Exp Clin Transplant. 2010 Sep;8(3):272.

13.

Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.

Nadasdy T, Allen C, Zand MS.

Hum Pathol. 2002 Apr;33(4):437-41.

PMID:
12055680
14.

Kidney infection with HIV-1 following kidney transplantation.

Stock PG.

J Am Soc Nephrol. 2014 Feb;25(2):212-5. doi: 10.1681/ASN.2013101112. Epub 2013 Dec 5. No abstract available.

15.

Extensive human cytomegalovirus (HCMV) genomic DNA in the renal tubular epithelium early after renal transplantation: Relationship with HCMV DNAemia and long-term graft function.

Li YT, Emery VC, Surah S, Jarmulowicz M, Sweny P, Kidd IM, Griffiths PD, Clark DA.

J Med Virol. 2010 Jan;82(1):85-93. doi: 10.1002/jmv.21662.

PMID:
19950242
16.

HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles.

Muthukumar T, Afaneh C, Ding R, Tsapepas D, Lubetzky M, Jacobs S, Lee J, Sharma V, Lee J, Dadhania D, Hartono C, McDermott J, Aull M, Leeser D, Kapur S, Serur D, Suthanthiran M.

Transplantation. 2013 Mar 15;95(5):711-20. doi: 10.1097/TP.0b013e31827ac322.

17.

Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.

Helanterä I, Koskinen P, Finne P, Loginov R, Kyllönen L, Salmela K, Grönhagen-Riska C, Lautenschlager I.

Transpl Int. 2006 Nov;19(11):893-900.

18.

The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective.

Yang Y, Hodgin JB, Afshinnia F, Wang SQ, Wickman L, Chowdhury M, Nishizono R, Kikuchi M, Huang Y, Samaniego M, Wiggins RC.

J Am Soc Nephrol. 2015 Jun;26(6):1450-65. doi: 10.1681/ASN.2014030287. Epub 2014 Nov 11.

20.

Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients.

Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Khatami MR, Nourbala MH, Pourfarziani V, Alavian SM.

J Gastroenterol Hepatol. 2003 Jul;18(7):836-40.

PMID:
12795757

Supplemental Content

Support Center